Oramed Pharmaceuticals
ORMP
#8894
Rank
HK$1.05 B
Marketcap
HK$26.45
Share price
-0.59%
Change (1 day)
37.85%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): HK$6.33

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$6.34. In 2024 the company made an earnings per share (EPS) of -HK$3.76 a decrease over its 2023 EPS that were of HK$1.10.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$6.33-268.48%
2024-HK$3.76-442.86%
2023HK$1.10-114.89%
2022-HK$7.3620.51%
2021-HK$6.1039.29%
2020-HK$4.38-31.71%
2019-HK$6.42-4.65%
2018-HK$6.738.86%
2017-HK$6.18-9.2%
2016-HK$6.8129.85%
2015-HK$5.248.06%
2014-HK$4.855.08%
2013-HK$4.623.51%
2012-HK$4.46137.5%
2011-HK$1.88-60%
2010-HK$4.70-0%
2009-HK$4.70-16.67%
2008-HK$5.64-25%
2007-HK$7.51700%
2006-HK$0.94303.56%
2005-HK$0.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
HK$27.50 333.76%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
HK$16.16 154.96%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-HK$46.49-833.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-HK$1.49-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-HK$2.35-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel